Table 2.
HUF sample no. | COCs (Total N) | Cleavage | Blastocyst rate | ||
---|---|---|---|---|---|
Total N | % | Total N | % | ||
1 | 26 | 21 | 81 | 10 | 48 |
2 | 31 | 26 | 84 | 8 | 31 |
3 | 28 | 23 | 82 | 6 | 26 |
4 | 28 | 21 | 75 | 16 | 76 |
5 | 47 | 22 | 47* | ||
6 | 30 | 23 | 77 | 13 | 57 |
7 | 40 | 31 | 78 | 9 | 29 |
8 | 24 | 18 | 75 | 9 | 50 |
9 | 19 | 15 | 79 | 8 | 53 |
10 | 21 | 15 | 71 | 4 | 27* |
11 | 30 | 22 | 73 | 9 | 41 |
12 | 28 | 20 | 71 | 6 | 30 |
13 | 34 | 24 | 71 | 10 | 42 |
14 | 22 | 17 | 77 | 5 | 29* |
The samples with <70% of cleavage or with <30% (asterisk) embryos reaching the blastocyst stage were considered not suitable for biobanking or use in ART, but the remaining 11 were considered suitable for both purposes.